Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07130149) titled 'Sonodynamic-Chemoradiotherapy Integration in Glioblastoma' on Aug. 12.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Yingjuan Zheng

Condition: Glioblastoma (GBM)

Intervention: Procedure: Sonodynamic Therapy (SDT)

Recruitment Status: Recruiting

Phase: Phase 2

Date of First Enrollment: October 1, 2024

Target Sample Size: 230

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07130149

Published by HT Digital Content Services with per...